Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration Catia MarzoliniLaurent A. DecosterdFerdy Lejeune ORIGINAL ARTICLE Pages: 433 - 440
Lack of correlation of MRP and γ-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells Besim OgretmenHamid BahadoriAhmad R. Safa ORIGINAL ARTICLE Pages: 441 - 446
Antihelicase action of CI-958, a new drug for prostate cancer Lapman LunPei-Ming SunNicholas R. Bachur ORIGINAL ARTICLE Pages: 447 - 453
Circumvention of P-glycoprotein-mediated multidrug resistance by S16020-2: kinetics of uptake and efflux in sensitive and resistant cell lines A. PierréS. LéonceG. Atassi ORIGINAL ARTICLE Pages: 454 - 460
Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer Murray S. WebbPatricia LoganMarcel B. Bally ORIGINAL ARTICLE Pages: 461 - 470
Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration Moustapha HassanZuzana HassanNils Kållberg ORIGINAL ARTICLE Pages: 471 - 478
Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors Matthew L. HanleyGertrude B. ElionHenry S. Friedman ORIGINAL ARTICLE Pages: 479 - 482
Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil Punya ShrivastavaMasaki HanibuchiSaburo Sone ORIGINAL ARTICLE Pages: 483 - 490
Jasplakinolide: interaction with radiation and hyperthermia in human prostate carcinoma and Lewis lung carcinoma Hideya TakeuchiGulshan AraBeverly Teicher ORIGINAL ARTICLE Pages: 491 - 496
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer Colleen J. GilbertWilliam P. PetrosWilliam P. Peters ORIGINAL ARTICLE Pages: 497 - 503
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically Primo N. Lara Jr.David R. GandaraMike DeGregorio ORIGINAL ARTICLE Pages: 504 - 508
Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration Nicolas B. TsavarisChristos Kosmas SHORT COMMUNICATIONS Pages: 509 - 511
Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levels Dick de VosPeter H. T. J. SleeDerek Stevenson SHORT COMMUNICATION Pages: 512 - 514